Cargando…

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas

OBJECTIVE: Osteosarcomas (OS) is one the most common primary bone malignancy in humans with the lungs metastasis in most cases. Metastasis and recurrence of OS is attributed to cancer stem cells (CSCs). Our study aimed to evaluate the clinical significance of CD133 and C-X-C chemokine receptor type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mardani, Azam, Gheytanchi, Elmira, Mousavie, Seyed Hamzeh, Madjd Jabari, Zahra, Shooshtarizadeh, Tina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294029/ https://www.ncbi.nlm.nih.gov/pubmed/31983166 http://dx.doi.org/10.31557/APJCP.2020.21.1.67

Ejemplares similares

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
por: Razmi, Mahdieh, et al.
Publicado: (2020)

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
por: Gójska-Grymajło, Anna, et al.
Publicado: (2018)

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
por: Gheytanchi, Elmira, et al.
Publicado: (2017)

Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines
por: Gheytanchi, Elmira, et al.
Publicado: (2021)

Isolation of Stem-Like Cancer Cells in Primary Endometrial Cancer Using Cell Surface Markers CD133 and CXCR4
por: Sun, Yi, et al.
Publicado: (2017)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients
por: Vafaei, Somayeh, et al.
Publicado: (2020)

Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
por: Gheytanchi, Elmira, et al.
Publicado: (2023)

Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
por: Ehteram, Hassan, et al.
Publicado: (2022)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
por: Kalantari, Elham, et al.
Publicado: (2022)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma
por: Caspa Gokulan, Ravindran, et al.
Publicado: (2021)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Erratum to: Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

Clinicopathological and prognostic significance of CXCR4 expression in osteosarcoma: a meta-analysis
por: Kusuma, I Gusti Ngurah Ananda Wira, et al.
Publicado: (2022)

CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line
por: Rajabi Fomeshi, Motahareh, et al.
Publicado: (2016)

CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021)

Successful management of multiple small bowel perforations due to polyarteritis nodosa
por: Mousavie, Seyed Hamzeh, et al.
Publicado: (2014)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Human osteosarcoma CD49f(−)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
por: Ying, Meidan, et al.
Publicado: (2012)

Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis
por: Razmi, Mahdieh, et al.
Publicado: (2021)

Evaluation of the Potential Association of Platelet Levels, Mean Platelet Volume and Platelet Distribution Width with Acute Appendicitis
por: Sepas, Hossein Najd, et al.
Publicado: (2019)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

CD133 Is a Marker of Bioenergetic Stress in Human Glioma
por: Griguer, Corinne E., et al.
Publicado: (2008)

CD133 Is a Marker For Long-Term Repopulating Murine Epidermal Stem Cells
por: Charruyer, A, et al.
Publicado: (2012)

CD133 in Breast Cancer Cells: More than a Stem Cell Marker
por: Brugnoli, Federica, et al.
Publicado: (2019)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3bl8up53unk9b8gmpooko9qkh